Hi! When we ask the T2B community to leave feedback for our events, we genuinely read through every comment, scrutinizing the data to see what’s working and what you want us to do more of (or less of!). That’s how we know that one of the traits you value most from our programming is that it promotes raw, honest dialogue and that we get to the heart of whatever topic is at hand quickly and in a real, meaningful way for the community. And that’s precisely what we’ll be doing at our inaugural...
3 days ago • 1 min read
Hi! The T2B community recently reached a very exciting milestone: Our membership is now 1,000-strong! From 0 - 1000 in less than 18 months (we launched in October 2023). That’s pretty incredible. Beyond the sheer growth, I continue to be impressed with the experience we have within our community. About half of our members have more than 15 years of experience, and two-thirds have over a decade of expertise. And those comms rockstars have been absolutely vital in helping us develop the next...
5 days ago • 2 min read
Hi! With ~1,600 oncology medicines and vaccines in development and the American Society of Clinical Oncology (ASCO) annual meeting around the corner, reporters are about to face a deluge of data and story pitches. So, among all of this information, what do journalists find compelling in a crowded news cycle? T2B’s Media Minds Roundtable is at it again. Their Q2 panel is called, “Top-Tier Perspective on ASCO and Beyond: How to Stand Out During Concentrated News Moments.” Taking place on...
7 days ago • 1 min read
Hi! If you’re anything like me, you love a conference. But how many times have you been to one you were really looking forward to, only to sit in a stuffy auditorium for hours on end being talked at? So, when we decided to plan the T2B Biopharma Comms Forum, we aimed to create the complete opposite. Taking place at Takeda’s 125 Binney St. location in Cambridge, MA on Tuesday, June 17th, the Forum’s theme is “The Next Chapter.” And we want this to be a two-way, interactive event: It’s not just...
10 days ago • 1 min read
Hi! As strategic corporate affairs advisors, we’re expected to earn trust across various stakeholders – from colleagues and executives to regulators, journalists, patients, investors, and the broader public. And those relationships ultimately shape our ability to lead, influence, and respond. But, whether navigating sensitive issues or simply keeping a program on track, we often face similar roadblocks: limited access, shifting priorities, and the need to quickly find common ground. So, we’re...
11 days ago • 2 min read
Hi! Last week, we were joined by Lauren Gardner, FDA reporter for POLITICO, and Tina Reed, healthcare editor at Axios, to explore the most pressing issues in Washington in the wake of the new administration. This Media Minds Roundtable-sponsored panel didn’t shy away from any of the big topics. We dove into the impact of regulatory changes and shifting policies and the ever-growing challenges for healthcare journalists, while examining how biopharma comms pros like us can best support the...
12 days ago • 1 min read
Hi! There’s just one day left to apply for a spot on the inaugural Investor Relations (IR) Roundtable. Together with roundtable chair Ami Bavishi, the five selected roundtable members will: Leverage their backgrounds and experience in biopharma investor relations into a forum for relevant conversations and sharing insights with your colleagues in the industry. Work collaboratively to determine how best to address investor relations amid real-world challenges and evolving global market...
18 days ago • 1 min read
Hi! There was a common theme threaded through every conversation at this year’s MassBio State of Possible conference: Communications is the essential bridge between scientific advancement and human impact. Every session came back to the fact that how we share stories determines whether breakthroughs reach those who need them, and I’ve picked out some moments that really reiterated this message for me. When science meets storytelling Brad Loncar, founder of BiotechTV, shared a personal...
19 days ago • 2 min read
Hi! Covering the new administration presents unending challenges for healthcare journalists. They’re having to track shifting policies, regulatory changes, and industry priorities, alongside all of the other barriers that inherently come with being a reporter. And they’ll no doubt be seeking the insights they require from trustworthy, authoritative biopharma stakeholders, like those represented by the T2B community. So, our next media panel on Thursday, April 10th @ 1-2 p.m. ET, will explore...
21 days ago • 1 min read
